This national effort will transform outcomes for patients with pancreatic cancer and revolutionize the way clinical trials are conducted.
We’re proud to partner with 12 initial medical centers who were selected through a competitive peer-review process. These 12 sites will provide treatment to patients enrolled in the Precision Promise clinical trial come spring 2017. Read more . . .